Cormorant Asset Management
Boston, Massachusettscormorant-asset.com
Overview
Cormorant Asset Management is a life sciences and healthcare focused investment firm that primarily invests in public and private biotechnology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Epicrispr Biotechnologies | Aug 2026 | Series C | Co-investor |
| Crystalys Therapeutics | Jul 2026 | Series B | Co-investor |
| Fore Biotherapeutics | Jul 2026 | Series D-2 Extension | Co-investor |
| Terremoto Biosciences | Apr 2026 | Series C | Co-investor |
| Faeth Therapeutics, Inc. | Feb 2026 | M&A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
